Spruce Biosciences (SPRB) Retained Earnings (2022 - 2025)
Spruce Biosciences (SPRB) has disclosed Retained Earnings for 4 consecutive years, with -$289.2 million as the latest value for Q4 2025.
- On a quarterly basis, Retained Earnings fell 15.57% to -$289.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$289.2 million, a 15.57% decrease, with the full-year FY2025 number at -$289.2 million, down 15.57% from a year prior.
- Retained Earnings was -$289.2 million for Q4 2025 at Spruce Biosciences, down from -$274.6 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$558000.0 in Q4 2022 to a low of -$289.2 million in Q4 2025.
- A 4-year average of -$193.8 million and a median of -$203.1 million in 2023 define the central range for Retained Earnings.
- Peak YoY movement for Retained Earnings: tumbled 35246.24% in 2023, then dropped 15.57% in 2025.
- Spruce Biosciences' Retained Earnings stood at -$558000.0 in 2022, then crashed by 35246.24% to -$197.2 million in 2023, then dropped by 26.89% to -$250.3 million in 2024, then decreased by 15.57% to -$289.2 million in 2025.
- Per Business Quant, the three most recent readings for SPRB's Retained Earnings are -$289.2 million (Q4 2025), -$274.6 million (Q3 2025), and -$266.4 million (Q2 2025).